NYSE to Commence Delisting Proceeding Against Ross Acquisition Corp II (ROSS)
The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the three securities enumerated below ("Securities") of Ross
Ross Acquisition Corp II Announces Suspension and Expected De-Listing From the New York Stock Exchange and Intention to Seek Listing on the Nasdaq Stock Market
PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company" or "we"), a special purpose acquisition company, announced today that the New York Stock Exchange (the "NYSE")
Press Release: Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination PALM BEACH, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Comp
Press Release: Ross Acquisition Corp II Announces Shareholder Approval of Extension of Deadline to Complete a Business Combination
Ross Acquisition Corp II Announces Shareholder Approval of Extension of Deadline to Complete a Business Combination PALM BEACH, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE
Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
PALM BEACH, Fla., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") announced that on August 31, 2023 it filed a definitive proxy statement (the "Definitive Proxy Statement") for
SPAC Ross Acquisition II Receives NYSE Notice for Delayed Form 10-Q Filing
Ross Acquisition Receives Non-Compliance Notice From NYSE
Ross Acquisition Corp II (ROSS) said late Monday it has been notified that it is not in compliance with the New York Stock Exchange's continued listing rules for failure to timely file its quarterly r
Ross Acquisition Corp II Receives NYSE Notice Regarding Delayed Form 10-Q Filing
PALM BEACH, Fla., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Ross Acquisition Corp II (NYSE:ROSS) (the "Company") announced today that it received a notice (the "Notice") on August 22, 2023 from the NYSE Regulation staff of the
Aprinoia Therapeutics Announces Mutual Termination of Business Combination Agreement With Ross Acquisition Corp. II
Aprinoia Therapeutics Announces Mutual Termination of Business Combination Agreement With Ross Acquisition Corp. II
SPAC Ross II, Biotech Aprinoia Mutually Terminate Merger Deal
Retail Earnings Provided Clear Customer Behavior Insights That Benefited Discount Retailers And Left High-End Retailers In The Dark
Like TJX Corporation (NYSE:TJX), Ross Stores Inc (NASDAQ:ROSS) thrived as consumers drifted away from high-end retailers. Ross Stores topped quarterly estimates and improved its outlook, with its shar
Ross Stores Sees 53 Week Period Ending Feb. 3, 2024 EPS $4.77-$4.99
Ross Stores Sees 53 Week Period Ending Feb. 3, 2024 EPS $4.77-$4.99
Ross Acquisition Corp II (NYSE:ROSS) Shares Sold by Mizuho Markets Americas LLC
Mizuho Markets Americas LLC lessened its position in shares of Ross Acquisition Corp II (NYSE:ROSS – Get Rating) by 93.8% in the 4th quarter, according to its most recent filing with the Securities &
Short Interest in Ross Acquisition Corp II (NYSE:ROSS) Decreases By 18.8%
Ross Acquisition Corp II (NYSE:ROSS – Get Rating) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 1,300 shares,
Ross Acquisition Corp II (NYSE:ROSS) Short Interest Down 24.0% in January
Ross Acquisition Corp II (NYSE:ROSS – Get Rating) saw a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 11,700 shares, a decline o
Ross Acquisition, Aprinoia Therapeutics Sign SPAC Merger Deal
07:36 AM EST, 01/18/2023 (MT Newswires) -- Ross Acquisition Corp. II (ROSS), a blank-check company, and Aprinoia Therapeutics have reached a definitive merger agreement that values the clinical-stage
Wilbur Ross-backed SPAC to Merge With Alzheimer's Drug Developer Aprinoia
Neurodegenerative Diseases Focused Company Goes Public Via Wilbur Ross-Backed SPAC, Joins Alzheimer's Race To Compete Biogen
Neurodegenerative diseases-focused Aprinoia Therapeutics has announced a business combination with Ross Acquisition Corp II (NYSE:ROSS), a special-purpose acquisition company founded by former Commerc
APRINOIA Therapeutics And ROSS Acquisition Corp II Announce Business Combination Agreement
APRINOIA Therapeutics And ROSS Acquisition Corp II Announce Business Combination Agreement
Ross Acquisition Corp II (NYSE:ROSS) Shares Sold by PEAK6 Investments LLC
PEAK6 Investments LLC cut its holdings in Ross Acquisition Corp II (NYSE:ROSS – Get Rating) by 29.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 40,172 s
No Data